A 6-Month Open-Label Study of Vortioxetine among Cancer Patients with Major Depressive Disorder (MDD)

Objective: Vortioxetine is a monoaminergic drug with a novel multimodal mechanism of action. We investigated its efficacy on depressive symptoms, cognitive function, and quality of life among cancer patients.Methods: In this multicenter, open-label, single-arm, observational study, patients received...

Full description

Bibliographic Details

Main Authors:	Chong Guan, Ng, Aya Ahmed, Abousheishaa, Sue Yin, Low, Nor Zuraida, Zainal, Kai Shin, Thong, Azizul, Awaluddin, Tsui Huei, Loo, Sapini, Yacob, Nik Ruzyanei, Nik Jaafar, Nur Iwana, Abdul Taib, Nurul Ain, Mohamad Kamal, Fuad, Ismail, Wan Zamaniah, Wi
Format:	Article
Language:	en
Published:	The Asian Pacific Journal of Cancer Prevention (APJCP) 2023
Subjects:	RZ Other systems of medicine
Online Access:	http://ir.unimas.my/id/eprint/42713/3/A%206-Month.pdf http://ir.unimas.my/id/eprint/42713/ https://journal.waocp.org/?sid=Entrez:PubMed&id=pmid:37642043&key=2023.24.8.2583
Tags:	Add Tag No Tags, Be the first to tag this record!